<DOC>
	<DOCNO>NCT02292043</DOCNO>
	<brief_summary>The investigator would evaluate effect novel method , HTEA cardiac function heart failure patient secondary idiopathic dilate cardiomyopathy post-myocardial infarction .</brief_summary>
	<brief_title>Effects HTEA ON Heart Failure Secondary Idiopathic Dilated Cardiomyopathy Post-myocardial Infarction</brief_title>
	<detailed_description>The investigator would evaluate effect novel method , HTEA cardiac function heart failure patient secondary idiopathic dilate cardiomyopathy post-myocardial infarction . The specific index 6 miniutes walk distance , echocardiography , NYHA , NTproBNP level , peripherial WBC , RBC , PLT , Cre , UA , K+ , Na+ upon entrance hospital 4 week HTEA treatment , 3 month discharge . The morbidity re-hospitalization would also calculate 3 month discharge .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>90 chronic cardiac failure patient hospital select divide two group . Vavular disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>